Drak2 overexpression results in increased β-cell apoptosis after free fatty acid stimulation

Journal of Cellular Biochemistry

Volumn 105, Issue 4, 2008, Pages 1073-1080

  Mao, Jianning ^a   Luo, Hongyu ^a   Wu, Jiangping ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Drak2; Islet; Type 2 diabetes

Indexed keywords

DRAK2 PROTEIN; FATTY ACID; FLICE INHIBITORY PROTEIN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL DEATH; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETRY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULINOMA; LIPID DIET; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DIET; FATTY ACIDS, NONESTERIFIED; GLUCOSE TOLERANCE TEST; INSULIN-SECRETING CELLS; MICE; OBESITY; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; UP-REGULATION;

MUS;

EID: 55549098591     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21910     Document Type: Article

References (20)

1. Ahren B. 2005. Type 2 diabetes,insulin secretion and beta-cell mass. Curr Mol Med 5:275-286.
2. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A. 1995. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 9:15-30.
3. Delarue J, Magnan C. 2007. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10:142-148.
4. Hamaguchi K, Gaskins HR, Leiter EH. 1991. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 40:842-849.
5. Inbal B, Shani G, Cohen O, Kissil JL, Kimchi A. 2000. Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis. Mol Cell Biol 20:1044-1054.
6. Jiao K, Liu H, Chen J, Tian D, Hou J, Kaye AD. 2008. Roles of plasma interleukin-6 and tumor necrosis factor-alpha and FFA and TG in the development of insulin resistance induced by high-fat diet. Cytokine 42:161-169.
7. Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846.
8. Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S. 1998. ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol Cell Biol 18:1642-1651.
9. Kawai T, Nomura F, Hoshino K, Copeland NG, Gilbert DJ, Jenkins NA, Akira S. 1999. Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity. Oncogene 18:3471-3480.
10. Lai E, Bikopoulos G, Wheeler MB, Rozakis-Adcock M, Volchuk A. 2008. Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic beta-cells. Am J Physiol Endocrinol Metab 294:E540-E550.
11. Lockwood DH, Amatruda JM. 1983. Cellular alterations responsible for insulin resistance in obesity and type II diabetes mellitus. Am J Med 75:23-31.
12. Mao J, Qiao X, Luo H, Wu J. 2006. Transgenic drak2 overexpression in mice leads to increased T cell apoptosis and compromised memory T cell development. J Biol Chem 281:12587-12595.
13. Matsumoto M, Miyake Y, Nagita M, Inoue H, Shitakubo D, Takemoto K, Ohtsuka C, Murakami H, Nakamura N, Kanazawa H. 2001. A serine/threonine kinase which causes apoptosis-like cell death interacts with a calcineurin B-like protein capable of binding Na(+)/H(+) exchanger. J Biochem (Tokyo) 130:217-225.
14. Murakami Y, Takamatsu H, Taki J, Tatsumi M, Noda A, Ichise R, Tait JF, Nishimura S. 2004. 18F-labelled annexin V: A PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging 31:469-474.
15. Rhodes CJ. 2005. Type 2 diabetes-a matter of {beta}-cell life and death? Science 307:380-384.
16. Sanjo H, Kawai T, Akira S. 1998. DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem 273:29066-29071.
17. Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for2030. Diab Care 27:1047-1053.
18. Winzell MS, Ahren B. 2004. The high-fat diet-fed mouse: A model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53(Suppl 3):S215-S219.
19. Wu Y, Han B, Luo H, Roduit R, Salcedo TW, Moore PA, Zhang J, Wu J. 2003. DcR3/TR6 effectively prevents islet primary nonfunction after transplantation. Diabetes 52:2279-2286.
20. Wu Y, Han B, Luo H, Shi G, Wu J. 2004. Dipeptide boronic acid, a novel proteasome inhibitor, prevents islet-allograft rejection. Transplantation 78:360-366.